Taxing Times for French Pharma - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Taxing Times for French Pharma
As the French Presidential campaign is underway, and politicians collaborate with businesses to revive a flagging economy, the pharmaceutical industry seizes the chance to lobby for equitable taxation to give the sector a much-needed boost.


Pharmaceutical Technology Europe


References

1. ARIIS, "Pétition d'ARIIS pour les présidentielles 2012" (ARIIS Website, 2012). http://www.ariis.fr, accessed 4 Apr., 2012.

2. A. Torsoli, "French Drugmakers Say Pricing Policy May Hamper Industry" (Bloomberg Website, 2012). http://mobile.bloomberg.com/, 4 Apr., 2012

3. The Pharma Letter, "Tax system for French drug firms to change" (The Pharma Letter Website, 2012). http://www.thepharmaletter.com/, accessed 4 Apr., 2012.

4. J. Cuadrado and C. Damiano, "French taxes specific to the pharmaceutical industry: cutting the health expenses or a different way of taxing the profitability of the pharmaceutical industry in France" in Tax on Transactions multi-jurisdictional guide (Practical Law Company Website, 2011). http://crossborder.practicallaw.com/, accessed 4 Apr., 2012.

5. Anon, "France loses AAA rating as euro governments downgraded" (BBC News Website, Jan. 12, 2012). http://www.bbc.co.uk/news/business-16552623, accessed 4 Apr., 2012.

6. H. Israël and C. Guionnet-Moalic, "France: How the Reform of the Tax Applicable to Pharmaceutical Product Turnover Will Affect Entities in this Field" (mondaq Website, 2005). http://www.mondaq.com/ accessed 4 Apr., 2012.

7. CSIS, Meeting of the Health Industries Strategic Advisory Board (Ministère de l'Économie, des Finances et de l'Industrie website, 2012). http://www.economie.gouv.fr, accessed 4 Apr., 2012.

8. Focus Reports, "France: The French Revolution" (Focus Reports Website, 2010). http://www.pharma.focusreports.net/, accessed 4 Apr., 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology Europe,
Click here